MRK vs MRVI · P/E 33, rev $16.61B vs rev $117.3M
Merck & Company Inc (MRK) versus Maravai Lifesciences Holdings Inc (MRVI) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. MRVI currently screens at market cap $1.93B.
Not investment advice. Open the MRK and MRVI stock pages for the full models.
Not investment advice.